Marginal Zone Lymphoma Clinical Trials

29 studies are recruiting for marginal zone lymphoma in the United States right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

By city

Boston, Massachusetts 5 Atlanta, Georgia 4 Columbus, Ohio 4 Houston, Texas 4 Miami, Florida 4 Milwaukee, Wisconsin 4 Nashville, Tennessee 4 New York, New York 4 Rochester, Minnesota 4 Salt Lake City, Utah 4 St Louis, Missouri 4 Tampa, Florida 4 Chapel Hill, North Carolina 3 Denver, Colorado 3 Duarte, California 3 Jacksonville, Florida 3 New Brunswick, New Jersey 3 Seattle, Washington 3

Studies, page 2

  1. SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

    International registry for cancer patients evaluating the feasibility and clinical utility of an Artificial Intelligence-based precision oncology clinical trial matching tool, powered by a virtual tumor boards (VTB) program, and its clinical impact on pts with advanced cancer to facilitate clinical…

    Stage
    Not phased
    Ages
    Any age
    Site
    Massive Bio SYNERGY-AI site, Birmingham, Alabama
    Locations
    68 in total
    Run by
    Massive Bio, Inc.

    See if you can join NCT03452774 on ClinicalTrials.gov

  2. Epcoritamab in Patients With Newly Diagnosed Marginal Zone Lymphoma (MZL)

    The purpose of this study is to assess if an investigational treatment of Epcoritamab will be beneficial for patients with Marginal Zone Lymphoma (MZL).

    Stage
    Phase 2
    Ages
    18 and older
    Site
    University of Miami, Miami, Florida
    Run by
    Izidore Lossos, MD

    See if you can join NCT06796998 on ClinicalTrials.gov

  3. Open-label of Loncastuximab Tesirine (ADCT-402) in Relapsed/Refractory Marginal Zone Lymphoma

    The purpose of this research study is to see if loncastuximab tesirine has any benefits at dose levels researchers found acceptable in earlier studies in patients with related forms of immune cell cancers. The researchers want to find out the effects (good and bad) that loncastuximab tesirine has o…

    Stage
    Phase 2
    Ages
    18 and older
    Site
    City of Hope National Medical Center, Duarte, California
    Locations
    4 in total
    Run by
    University of Miami

    See if you can join NCT05296070 on ClinicalTrials.gov

  4. Local Manufacture of CAR T-Cell Products for the Treatment of B-Cell Lymphoma and B-Acute Lymphoblastic Leukemia

    This trial aims to demonstrate the feasibility of this approach to reliably generate product and to safely administer the product to patients who have B-Cell Lymphoma and B-Acute Lymphoblastic Leukemia.

    Stage
    Phase 2
    Ages
    18 to 79
    Site
    AHN Cancer Institute - West Penn Hospital, Pittsburgh, Pennsylvania
    Run by
    John Lister

    See if you can join NCT05281809 on ClinicalTrials.gov

How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.

What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.

Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.